[DPHARMA] YoY TTM Result on 31-Mar-2011 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-May-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Mar-2011 [#1]
Profit Trend
QoQ- 2.77%
YoY- 3.79%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Revenue 165,062 137,091 141,205 135,625 124,896 123,065 114,918 6.21%
PBT 42,396 35,384 35,723 36,493 35,638 34,863 41,521 0.34%
Tax -7,243 -9,378 -8,233 -7,030 -7,252 -7,795 -10,093 -5.37%
NP 35,153 26,006 27,490 29,463 28,386 27,068 31,428 1.88%
-
NP to SH 35,153 26,006 27,490 29,463 28,386 27,068 31,428 1.88%
-
Tax Rate 17.08% 26.50% 23.05% 19.26% 20.35% 22.36% 24.31% -
Total Cost 129,909 111,085 113,715 106,162 96,510 95,997 83,490 7.64%
-
Net Worth 190,050 176,143 170,824 162,320 146,967 137,340 120,710 7.85%
Dividend
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Div 24,289 19,431 24,987 6,402 16,743 20,833 47,174 -10.46%
Div Payout % 69.10% 74.72% 90.90% 21.73% 58.98% 76.97% 150.11% -
Equity
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Net Worth 190,050 176,143 170,824 162,320 146,967 137,340 120,710 7.85%
NOSH 138,723 138,695 138,881 138,735 138,648 138,727 138,747 -0.00%
Ratio Analysis
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
NP Margin 21.30% 18.97% 19.47% 21.72% 22.73% 21.99% 27.35% -
ROE 18.50% 14.76% 16.09% 18.15% 19.31% 19.71% 26.04% -
Per Share
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
RPS 118.99 98.84 101.67 97.76 90.08 88.71 82.83 6.22%
EPS 25.34 18.75 19.79 21.24 20.47 19.51 22.65 1.88%
DPS 17.50 14.00 18.00 4.61 12.06 15.00 34.00 -10.47%
NAPS 1.37 1.27 1.23 1.17 1.06 0.99 0.87 7.85%
Adjusted Per Share Value based on latest NOSH - 138,735
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
RPS 17.16 14.25 14.68 14.10 12.98 12.79 11.95 6.21%
EPS 3.65 2.70 2.86 3.06 2.95 2.81 3.27 1.84%
DPS 2.53 2.02 2.60 0.67 1.74 2.17 4.90 -10.42%
NAPS 0.1976 0.1831 0.1776 0.1687 0.1528 0.1428 0.1255 7.85%
Price Multiplier on Financial Quarter End Date
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Date 31/03/14 29/03/13 30/03/12 31/03/11 31/03/10 31/03/09 31/03/08 -
Price 3.03 2.23 2.40 2.35 2.40 2.10 2.60 -
P/RPS 2.55 2.26 2.36 2.40 2.66 2.37 3.14 -3.40%
P/EPS 11.96 11.89 12.13 11.07 11.72 10.76 11.48 0.68%
EY 8.36 8.41 8.25 9.04 8.53 9.29 8.71 -0.68%
DY 5.78 6.28 7.50 1.96 5.03 7.14 13.08 -12.72%
P/NAPS 2.21 1.76 1.95 2.01 2.26 2.12 2.99 -4.91%
Price Multiplier on Announcement Date
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Date 20/05/14 27/05/13 17/05/12 25/05/11 25/05/10 26/05/09 21/05/08 -
Price 3.09 2.51 2.38 2.57 2.38 2.34 2.55 -
P/RPS 2.60 2.54 2.34 2.63 2.64 2.64 3.08 -2.78%
P/EPS 12.19 13.39 12.02 12.10 11.62 11.99 11.26 1.33%
EY 8.20 7.47 8.32 8.26 8.60 8.34 8.88 -1.31%
DY 5.66 5.58 7.56 1.79 5.07 6.41 13.33 -13.29%
P/NAPS 2.26 1.98 1.93 2.20 2.25 2.36 2.93 -4.23%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment